PROGRAMMA FINALE - ABSTRACTS ONLINE

POSTER SESSIONS ABSTRACTS

Poster Session V (A)
P-5A PHARMACOLOGY OF THE NERVOUS SYSTEM (PART 1)

 

P-5/1 Demonstrating peripheral restriction of novel cannabinoid CB1 antagonist TM38837 by evaluating for expression of conditioned fear in mice
V. Micale, PK. Nørregaard, CT. Wotjak (Munich, Hørsholm)
P-5/2 Effects of gestational all-trans retinoic acid treatment on the complex I of mitochondrial respiratory chain in the rat cerebellum
D. Signorile, N. Sardaro , D. De Rasmo, S. Papa, P. Borracci, MR. Carratù ( Bari)
P-5/3 F3/Contactin gene knockdown results in upregulation of the dopaminergic phenotype in the basal ganglia
A. Massaro, A. Bizzoca, P. Corsi, M. Pinto, M. Persichella, A. Giustino, G. Gennarini, MR. Carratù (Bari)
P-5/4 Role of functional polymorphisms and haplotypes of the serotonin transporter gene in Medication Overuse Headache
S. Terrazzino, C. Tassorelli, G. Sances , M. Viana, G. Nappi, PL. Canonico, AA. Genazzani (Novara, Pavia)
P-5/5 Neuroprotective and antiamyloidogenic effect of Substance P by activation of α -secretase-mediated amyloid precursor protein cleavage
R. Marolda, C. Petrella, MT. Ciotti, R. Possenti, P. Calissano, C. Severini ( Roma)
P-5/6 Chronic caffeine intake reduces the survival in a mice model of amyotrophic lateral sclerosis.
R.L. Potenza, A. Ferrante, M. Armida , A. Pezzola, A. Matteucci, P. Popoli (Roma)
P-5/7 Understanding β-Amyloid-induced toxicity by a chemical-biology approach.
M. Camarri, L. Terzuoli , T. Ferraro, G. Pollio, D. Diamanti, L. Magnoni, S. Bernocco, C. Scali, S. Rasmussen, HB. Nielsen, AR. Bilia, A. Karioti, L. Millucci, A. Caricasole, D. Franceschini (Siena, Lyngby, Firenze)
P-5/8 Viral vector delivery of mutant huntingtin as model of huntington's disease in the rat: in vivo and in vitro study.
C. Scali, I. Ceccarelli, R. Remelli, D. Franceschini, L. Rossini , G. Pollio, M. Camarri, I. Biotti, A. Cappelli, V. Miragliotta, P. Fiengo, A. Caricasole, G. Gaviraghi (Siena)
P-5/9 RANTES-glutamate interaction in Central Nervous System: a glial to neuron cross-talk relevant to central neuroinflammation
S. Di Prisco , M. Summa, V. Chellakudam, A. Pittaluga (Genova)
P-5/10 Salviae neoclerodane derivatives differently affect catecholamine release in mammals brains: comparison with Salvinorin A.
G. Olivero, S. Di Prisco, M. Summa , E. Giacomelli, M. Grilli, A. Bisio, G. Romussi, M. Marchi, A. Pittaluga (Genova)
P-5/11 Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned parkinsonian rats
A. Ferrigno, MT. Armentero, V. Rizzo, A. Bianchi, G. Ambrosi , P. Richelmi , F. Blandini , M. Vairetti ( Pavia)
P-5/12 Adult neural stem cells prevent L-dopa and dopamine autoxidation in vitro
G. Calia, V. Mazzarello, S. Dedola, G. Bazzu, R. Migheli, P.A. Serra, M.S. Desole, G. Rocchitta (Sassari)
P-5/13 The new FAAH inhibitorST4070 (1-biphenyl-4-ylethenyl piperidine-1-carboxilate)reduced anxiety-like behavior in the elevated plus maze in young male rats
S. Di Serio, V. Dainese, D. Guaraldi, M.G. Scrocco , A. Caprioli , F. Borsini (Pomezia - Roma)
P-5/14 Natural-like curcumin derivatives protect PC12 cells against Mn, MPP+ and H2O2 damage
S. Dedola, D. Fabbri, M.A. Dettori, G. Delogu, P. Ruzza, P.A. Serra, M.S. Desole, R. Migheli (Sassari)
P-5/15 Dual asymmetric-flow microdialysis for monitoring the effects of MPTP and d-amphetamine on striatal dopamine and energy metabolism in freely moving rats
G. Bazzu, G. Calia, G. Rocchitta, R. Migheli, M.S. Desole, P.A. Serra (Sassari)
P-5/16 Palmitoylethanolamide exerts neuroprotective actions in a murine model of Parkinson's disease
E. Esposito, E. Mazzon, I. Paterniti, S. Cuzzocrea (Messina)
P-5/17 Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine
C. Cifani, B.M. Navarre, S.G. Nair, C.L. Pickens , J.M. Bossert, Y. Shaham (Baltimore, USA)
P-5/18 Effect of neuropeptide S receptor antagonists and partial agonists on highly palatable food consumption in rats
C. Cifani, M.V. Micioni Di B, N. Cannella, M. Ubaldi, R. Guerrini , G. Calò, M. Massi, R. Ciccocioppo (Camerino (MC), Ferrara)
P-5/19 Cycles of food restriction increase the orexigenic effect of Nociceptin/Orphanin FQ (N/OFQ) and Neuropeptide Y (NPY) in female rats
C. Cifani, M.V. Micioni Di B, M. Ubaldi, R. Ciccocioppo, M. Massi (Camerino (MC))
P-5/20 Effect of the orexin receptors antagonists in a model of binge eating in female rats
M.V. Micioni Di Bonaventura, C. Cifani, M. Corsi, D. Montanari, R. Ciccocioppo, M. Massi, E. Merlo-Pich, L. Piccoli (Camerino (MC), Verona)
P-5/21 Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating
C. Cifani, M.V. Micioni Di B, G. Vitale , V. Ruggieri, R. Ciccocioppo, M. Massi (Camerino (MC), Modena)
P-5/22 Differential changes in CB1 receptor expression and regulation of GABAergic and glutamatergic functions in the striatum of Huntington’s disease mice.
V. Chiodi, L. Ferraro, M. Uchigashima, A. Martire, S. Beggiato, M. Armida, A. Ferrante, R.L. Potenza, M. Watanabe, S. Tanganelli, M.R. Domenici, P. Popoli (Roma, Ferrara, Sapporo (Japan))
P-5/23 Effect of gender and age on risperidone plasma concentrations in pediatric patients with psychotic disorders
C. D'Arrigo, V. Santoro, A. Gagliano, E. Germanò, R. Siracusano, E. Spina (Messina)
P-5/24 Low-frequency rTMS regulates emotional behaviour and dendritic plasticity in dentate gyrus
R. Crupi, M. Cambiaghi, R. Hen, E. Spina, F. Battaglia ( Messina, Milano, New York)
P-5/25 Electrophysiological effects of CHF5074 on rat hippocampus: protection against in vitro OGD
D. Mango, M.B. Panico, V. Porrini , I. Sarnico, M. Pizzi, B.P. Imbimbo , N.B. Mercuri , R. Nisticò (Roma, Brescia, Parma, Roma, Arcavacata di Rende)
P-5/26 A microfluidic device for investigating biomolecular cascades between different CNS cell populations
N. Tonna, F. Bianco , R. Lovchik, E. Delamarche, M. Matteoli (Milano, Ruschlikon)
P-5/27 Predictive role of the scavenger receptor CD36 in course of neurodegeneration in APP23 mice
M. Giunta, M. Morbin, G. Giaccone, S.M. Bonomo, A.E. Rigamonti, S.G. Cella (Milano)
P-5/28 Molecular mechanisms underlying melanocortin-induced neurogenesis following ischemic stroke
L. Spaccapelo, M. Galantucci, A. Ottani, M. Contri, F. Cavallini, D. Zaffe, D. Giuliani, S. Guarini (Modena)
P-5/29 Direct evidence that melanocortin MC4 receptor stimulation induces neuroprotection against ischemic stroke
A. Ottani, A. Bitto, L. Spaccapelo, M. Galantucci, L. Minutoli, D. Altavilla, E. Novellino, P. Grieco, D. Zaffe, F. Squadrito, D. Giuliani, S. Guarini (Modena, Messina, Napoli)
P-5/30 Excessive and precocious glutamate release in the spinal cord of a mouse model of amyotrophic lateral sclerosis
T. Bonifacino, M. Milanese, F. Onofri , L. Musazzi, D. Tardito, M. Messa, C. Usai, G. Racagni, F. Benfenati, M. Popoli, G. Bonanno (Genova, Milano, New Haven)
P-5/31 Intravenous mesenchymal stem cells improve survival and motor functions in symptomatic mutant SOD1/G93A mice
M. Milanese, T. Bonifacino, F. Giribaldi, M.C. Principato, S. Morando, S. Casazza, D. Giunti, L. Vergani, E. Carminati, A. Uccelli, A. Voci, G. Bonanno (Genova)
P-5/32 Epigenetic modifications in transgenic mouse with human polymorphism (Val66Met) of BDNF gene
S. Corna, A. Mallei, C. Benevento, D. Tardito, G. Racagni, F.S. Lee, M. Popoli (Milano, New York)
P-5/33 Reduction of SNAP-25 expression enhances evoked glutamatergic transmission and induces epileptiform activity associated with memory defects
I. Corradini, F. Antonucci, A. Donzelli, S. De Astis, R. Martucci, D. Braida, C. Verderio, M. Sala, M. Matteoli (Milano)
P-5/34 Effects of chronic antidepressant treatments on expression of inflammatory biomarkers in the rat hypothalamus
C. Montanari, S. Alboni, C. Benatti, F. Tascedda, N. Brunello ( Modena)
P-5/35 Depression and Epilepsy in a genetic animal model: pharmacology and hippocampal damage.
E. Russo, R. Citraro, F. Scicchitano, I. Perrotta, G. Donato, P. De Fazio, G. De Sarro (Catanzaro, Cosenza)
P-5/36 Central effects of a local inflammation on three commonly used mouse strains with a different anxious phenotype
C. Benatti, S. Alboni, C. Montanari, F. Tascedda, N. Brunello, JMC. Blom (Modena)
P-5/37 Mesoangioblast-based supplementation of neurotrophic factors for the treatment of neuronal damage.
S. Zucchini, T. Su, A. Binaschi , B. Paradiso, R. Bovolenta , M. Barbieri, R. Scardigli, L. Fasulo , G. Cossu, A. Cattaneo, M. Simonato (Ferrara, Roma, Milano)
P-5/38 Preclinical antiepileptic and antiepileptogenic effects of alpha-lactoalbumin, a whey protein rich in tryptophan.
R. Citraro, S. De Fazio, F. Scicchitano, S. Chimirri, A. Urzino, M. Menniti, R. Marra, G. De Sarro, E. Russo (Catanzaro)
P-5/39 Effects of the continuous delivery of a potent NOP receptor antagonist, [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), on molecular, cellular and behavioral alterations in a chronic model of stress.
M. Filaferro, S. Zucchini, V. Ruggieri , G. Vitale, C. Novi , C. Cifani, M. Massi, M. Simonato (Modena, Ferrara, Camerino)
P-5/40 Topiramate in the Treatment of Obesity Induced by Psychotropic Drugs in a Patient with Bipolar Disorder: A Case Report
W. Milano, M. De Rosa, L. Milano, G. Nolfe, C. Petrella, A. Capasso (Napoli, Salerno)
P-5/41 Serotoninergic or dopaminergic pathways influence coping behavior in mice after neuroleptics treatment.
S. De Fazio, E. Russo, S. Gratteri, M. Aribitrio, G. Trombetta, E. Donato Di Paola, G. De Sarro (Catanzaro, Vibo Valentia)